Mediators and moderators of treatment effects in randomized clinical trials

Archives of General Psychiatry

Volumn 59, Issue 10, 2002, Pages 877-883

  Kraemer, Helena Chmura ^a   Wilson, G Terence ^a   Fairburn, Christopher G ^a   Agras, W Stewart ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FLUVOXAMINE MALEATE; PINDOLOL; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR;

ATTENTION DEFICIT DISORDER; BEHAVIOR THERAPY; BULIMIA; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; HUMAN; LOW BIRTH WEIGHT; MENTAL DISEASE; OUTCOMES RESEARCH; PREMATURITY; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; REVIEW; STANDARD; TREATMENT OUTCOME;

EID: 0036792805     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.59.10.877     Document Type: Review

References (37)

1. Meinert CL. Clinical Trials: Design, Conduct, and Analysis. New York, NY: Oxford University; 1986.
2. Borenstein M. The case for confidence intervals in controlled clinical trials. Control Clin Trials. 1994;15:411-428.
3. Jacobson NS, Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol. 1991;59:12-19.
4. Kraemer HC. Reporting the size of effects in research studies to facilitate assessment of practical or clinical significance. Psychoneuroendocrinology. 1993;17:527-536.
5. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51:1173-1182.
6. Roth A, Fonagy P. What Works for Whom: A Critical Review of Psychotherapy Research. New York, NY: Guilford Press; 1966.
7. Group PMR. Matching alcoholism treatment to client heterogeneity: Project MATCH posttreatment drinking outcomes. J Stud Alcohol. 1997;58:7-29.
8. Longabaugh R, Wirtz PW, DiClemente CC, Litt M. Issues in the development of client-treatment matching hypotheses. J Stud Alcohol. 1994;12:46-59.
9. Kraemer H, Kazdin A, Offord D, Kessler R, Jensen P, Kupfer D. Coming to terms with the terms of risk. Arch Gen Psychiatry. 1997;54:337-343.
10. Kazdin AE, Weisz JR. Identifying and developing empirically supported child and adolescent treatments. J Consult Clin PsychoL 1998;66:19-36.
11. Hyman SE. The millennium of mind, brain, and behavior. Arch Gen Psychiatry. 2000;57:88-89.
12. Morganstern J, Longabaugh R. Cognitive behavioral treatment for alcohol dependence: A review of mediating mechanisms and effectiveness. Addiction. 2000;10:1475-1490.
13. Craighood LW, Agras WS. Mechanisms of action in cognitive-behavioral and pharmacological interventions for obesity and bulimia nervosa. J Consult Clin Psychol. 1991;59:115-125.
14. Clark DM, Panic disorder and social phobia. In: Clark DM, Fairburn CG, eds. Science and Practice of Cognitive Behaviour Therapy. New York, NY: Oxford University Press; 1997:119-153.
15. Kraemer HC, Stice E, Kazdin A, Kupfer D. How do risk factors work together to produce an outcome? mediators, moderators, and independent, overlapping and proxy risk factors. Am J Psychiatry. 2001;158:848-856.
16. Kraemer HC, Kazdin AE, Offord DR, Kessler RC, Jensen PS, Kupfer DJ. Measuring the potency of a risk factor for clinical or policy significance. Psychol Methods. 1999;4:257-271.
17. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.
18. Hedges LV. Estimation and testing for differences in effect size: a comment on Hsu. Psychol Bull. 1982;91:691-693.
19. Rosenthal R. Parametric measures of effect size. In: Cooper H, Hedges LV, eds. The Handbook of Research Synthesis. New York, NY: Russell Sage Foundation; 1994:231-244.
20. Infant Health and Development Program. Enhancing the outcomes of low birth weight, premature infants: a multisite randomized trial. JAMA. 1990;263:3035-3042.
21. Brooks-Gunn J, McCarton CM, Casey PH, BrooksGunn J, McCarton CM, Casey PH, McCormick MC, Bauer CR, Bernbaum JC, Tyson J, Swanson M, Bennett FC, Scott DT. Early intervention in lowbirth-weight premature infants. JAMA. 1994;272:1257-1262.
22. Smeraldi E, Zanardi R, Benedetti F, DiBella D, Perez J, Catalano M. Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol Psychiatry. 1998;3:508-511.
23. Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with Attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 1999;56:1088-1096.
24. The MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder: Multimodal Treatment Study of Children With ADHD. Arch Gen Psychiatry. 1999;56:1073-1086.
25. Agras WS, Walsh BT, Fairburn CG, Wilson GT, Kraemer HC. A multicenter comparison of cognitive-behavioral therapy and interpersonal psychotherapy for bulimia nervosa. Arch Gen Psychiatry. 2000;57:459-466.
26. Ramey CT, Bryant DM, Wasik DH, Sparling JJ, Fendt KH, LaVange LM. Infant Health and Development Program for low birth weight, premature infants: program elements, family participation, and child intelligence. Pediatrics. 1992;89:454-465.
27. Whisman M. Mediator and moderators of change in cognitive therapy of depression. Psychol Bull. 1993;114:248-265.
28. Davis CE. The effect of regression to the mean in epidemiologic and clinical studies. Am J Epidemiol. 1976;104:493-498.
29. Samuels ML. Statistical reversion toward the mean: more universal than regression toward the mean. Am Stat. 1991;45:344-346.
30. Senn S. Regression to the mean. Stat Methods Med Res. 1997;6:99-102.
31. Stigler SM. Regression towards the mean, historically considered. Stat Methods Med Res. 1997;6:103-114.
32. Holmbeck GN. Toward terminological, conceptual, and statistical clarity in the study of mediators and moderators: examples from the child-clinical and pediatric psychology literatures. J Consult Clin Psychol. 1997;65:599-610.
33. Meinert CL. Toward more definitive clinical trials. Control Clin Trials. 1980;1:249-261.
34. Wilson GT. Rapid response to cognitive behavior therapy. Clin Psychol. 1999;6:289-292.
35. Ilardi SS, Craighead WE. The role of nonspecific factors in cognitive-behavior therapy for depression. Clin Psychol. 1994;1:138-156.
36. DeRubeis RJ, Evans MD, Hollon SD, Garvey MJ, Grove WM, Tuason VB. How does cognitive therapy work? cognitive change and symptom change in cognitive therapy and pharmacotherapy for depression. J Consult Clin Psychol. 1990;58:862-869.
37. Wilson GT, Loeb KL, Walsh BT, Labouvie E, Petkova E, Liu X, Waternaux C. Psychological versus pharmacological treatment of bulimia nervosa: predictors and processes of change. J Consult Clin Psychol.1999;67:451-459.